Parafend Plus Oral Suspension
Parafend Plus Oral Suspension
Authorised
- Oxfendazole
- Closantel
Product identification
Medicine name:
Parafend Plus Oral Suspension
Parafend Plus Oral Suspension
Active substance:
- Oxfendazole
- Closantel
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxfendazole25.00milligram(s)1.00millilitre(s)
-
Closantel50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Sheep
-
Meat and offal42day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- White low-density polyethylene backpacks of 1L.
- White low-density polyethylene backpacks of 2.5 L.
- White low-density polyethylene backpacks of 5 L.
- White low-density polyethylene backpacks of 2 x 5 L.
- White low-density polyethylene 10L jerry-can.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22664/070/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0149/001
Concerned member states:
-
France
-
Italy
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: